SCHEMBL5216231

SCHEMBL5216231

CCOC(=O)c1c(OCCO)c2cc(OC)ccc2n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.52
CCR2 P41597 3/20 0.48
PLA2G2A P14555 6/20 0.46
LMNA P02545 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
TSHR P16473 2/20 0.46
CYP2C19 P33261 2/20 0.46
PMP22 Q01453 2/20 0.46
MAPT P10636 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
RGS12 O14924 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.46
NFKB1 P19838 1/20 0.46
MAPK1 P28482 1/20 0.46
GNAI1 P63096 1/20 0.46
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5214261 0.92 ABCB11 (0.51) ABCB11CCR2PLA2G2ALMNACYP1A2
SCHEMBL5213205 0.89 ABCB11 (0.66) ABCB11CCR2PLA2G2ALMNACYP1A2
SCHEMBL5212313 0.83 ABCB11 (0.62) ABCB11CCR2PLA2G2ALMNACYP1A2
SCHEMBL6598438 0.82 ABCB11 (0.59) ABCB11CCR2PLA2G2ALMNAMAPT
SCHEMBL6599266 0.81 ABCB11 (0.77) ABCB11CCR2LMNATSHRMAPT
SCHEMBL6782383 0.78 ABCB11 (0.56) ABCB11CCR2LMNACYP1A2CYP3A4
SCHEMBL5214893 0.77 CCR2 (0.56) ABCB11CCR2LMNACYP1A2CYP3A4
SCHEMBL6389006 0.77 CCR2 (0.45) ABCB11CCR2PLA2G2ALMNACYP1A2
SCHEMBL8061260 0.77 CCR2 (0.45) ABCB11CCR2PLA2G2ALMNACYP1A2
SCHEMBL6389010 0.77 CCR2 (0.45) ABCB11CCR2PLA2G2ALMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173421-B1 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2007-10-03 EP disclosed
US-6833387-B1 3-substituted indoles; inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis; inflammatory diseases ASTRAZENECA AB (SE) 2004-12-21 US disclosed
EP-1173421-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS AstraZeneca AB (SE) 2002-01-23 EP disclosed
WO-2000046199-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2000-08-10 WO disclosed